S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
New CBOE “special perk” helps traders target income every weekend (Ad)
How does the Consumer Price Index affect the stock market?
3 reasons to buy AMD before 2024
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

Assertio (ASRT) Short Interest Ratio & Short Volume

$1.09
-0.04 (-3.54%)
(As of 12/8/2023 ET)
Compare
Today's Range
$1.09
$1.16
50-Day Range
$1.02
$2.57
52-Week Range
$0.87
$8.01
Volume
812,361 shs
Average Volume
1.97 million shs
Market Capitalization
$103.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Assertio Short Interest Data

Current Short Volume
8,670,000 shares
Previous Short Volume
8,440,000 shares
Change Vs. Previous Month
+2.73%
Dollar Volume Sold Short
$9.88 million
Short Interest Ratio / Days to Cover
5.1
Last Record Date
November 15, 2023
Outstanding Shares
94,669,000 shares
Percentage of Shares Shorted
9.16%
Today's Trading Volume
812,361 shares
Average Trading Volume
1,967,028 shares
Today's Volume Vs. Average
41%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Assertio ?

Sign up to receive the latest short interest report for Assertio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ASRT Short Interest Over Time

ASRT Days to Cover Over Time

ASRT Percentage of Float Shorted Over Time


Assertio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20238,670,000 shares $9.88 million +2.7%N/A5.1 $1.14
10/31/20238,440,000 shares $18.15 million +3.1%N/A5.7 $2.15
10/15/20238,190,000 shares $19.16 million -7.0%N/A3.7 $2.34
9/30/20238,810,000 shares $22.55 million -2.7%N/A4 $2.56
9/15/20239,050,000 shares $24.93 million -2.7%N/A4 $2.76
8/31/20239,300,000 shares $30.50 million +1.2%N/A4.1 $3.28
8/15/20239,190,000 shares $29.59 million -14.4%N/A4.2 $3.22
7/31/202310,730,000 shares $61.05 million +0.9%N/A4.6 $5.69
7/15/202310,630,000 shares $54.74 million -3.5%N/A5.5 $5.15
6/30/202311,010,000 shares $59.67 million +7.6%N/A5.5 $5.42
6/15/202310,230,000 shares $62.81 million +0.6%N/A4.9 $6.14
5/31/202310,170,000 shares $64.38 million +2.6%N/A4.8 $6.33
5/15/20239,910,000 shares $72.54 million +3.3%N/A4 $7.32
4/30/20239,590,000 shares $52.84 million -1.3%N/A4 $5.51
4/15/20239,720,000 shares $61.14 million +8.7%N/A4.8 $6.29
3/31/20238,940,000 shares $56.95 million +5.7%N/A4.5 $6.37
3/15/20238,460,000 shares $48.05 million +57.8%N/A4.6 $5.68
2/28/20235,360,000 shares $29.64 million -43.2%N/A3.4 $5.53
2/15/20239,440,000 shares $48.14 million +12.0%N/A7.4 $5.10
1/31/20238,430,000 shares $34.65 million +8.2%N/A7.9 $4.11
1/15/20237,790,000 shares $32.64 million +4.9%N/A8.1 $4.19
12/30/20227,430,000 shares $31.95 million +14.0%N/A9 $4.30
12/15/20226,520,000 shares $23.73 million +11.5%N/A8.3 $3.64
11/30/20225,850,000 shares $18.14 million -0.5%N/A8.3 $3.10
11/15/20225,880,000 shares $17.29 million +2.6%N/A7.2 $2.94
10/31/20225,730,000 shares $14.78 million -1.4%N/A6.1 $2.58
10/15/20225,810,000 shares $12.67 million -2.5%N/A5.5 $2.18
9/30/20225,960,000 shares $13.53 million +2.4%N/A5.3 $2.27
9/15/20225,820,000 shares $14.20 million +29.6%N/A4.7 $2.44
8/31/20224,490,000 shares $11.45 million +509.7%N/A3.7 $2.55
8/15/2022736,400 shares $2.72 million +2.6%N/A0.6 $3.70
7/31/2022718,100 shares $2.80 million -23.9%N/A0.7 $3.90
7/15/2022943,600 shares $2.66 million +9.4%N/A1 $2.82
6/30/2022862,500 shares $2.54 million +6.1%N/A0.9 $2.95
6/15/2022813,200 shares $2.29 million +2.3%N/A0.8 $2.82
5/31/2022795,300 shares $2.39 million -19.4%N/A0.8 $3.01
5/15/2022987,200 shares $2.82 million +68.8%N/A1.1 $2.86
4/30/2022584,700 shares $1.23 million -27.4%N/A0.7 $2.11
4/15/2022805,400 shares $2.38 million -1.0%N/A0.9 $2.95
3/31/2022813,400 shares $2.33 million +57.9%N/A0.9 $2.87













ASRT Short Interest - Frequently Asked Questions

What is Assertio's current short interest?

Short interest is the volume of Assertio shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 8,670,000 shares of ASRT short. Learn More on Assertio's current short interest.

What is a good short interest ratio for Assertio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASRT shares currently have a short interest ratio of 5.0. Learn More on Assertio's short interest ratio.

Which institutional investors are shorting Assertio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Assertio: Wolverine Asset Management LLC, UBS Group AG, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Assertio's short interest increasing or decreasing?

Assertio saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 8,670,000 shares, an increase of 2.7% from the previous total of 8,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Assertio's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Assertio: GlycoMimetics, Inc. (1.36%), Annovis Bio, Inc. (6.88%), Kinnate Biopharma Inc. (5.38%), 2seventy bio, Inc. (26.17%), Milestone Pharmaceuticals Inc. (1.15%), BioXcel Therapeutics, Inc. (25.12%), Oncolytics Biotech Inc. (2.03%), Vaxxinity, Inc. (11.63%), Organigram Holdings Inc. (6.40%), Capricor Therapeutics Inc (4.42%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Assertio stock?

Short selling ASRT is an investing strategy that aims to generate trading profit from Assertio as its price is falling. ASRT shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Assertio?

A short squeeze for Assertio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASRT, which in turn drives the price of the stock up even further.

How often is Assertio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASRT, twice per month. The most recent reporting period available is November, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ASRT) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -